Modulation of drug cytotoxicity by Iressa (ZD1839) in pancreatic cancer cell lines.
Rosetti, M
Modulation of drug cytotoxicity by Iressa (ZD1839) in pancreatic cancer cell lines. [electronic resource] - Cancer biology & therapy Oct 2005 - 1089-95 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1538-4047
10.4161/cbt.4.10.1995 doi
Antineoplastic Agents--blood
Apoptosis--drug effects
Carcinoma--pathology
Cell Line, Tumor
Cell Survival--drug effects
Dose-Response Relationship, Drug
Drug Therapy, Combination
Drug-Related Side Effects and Adverse Reactions
Enzyme Inhibitors--blood
ErbB Receptors--antagonists & inhibitors
Gefitinib
Humans
Mitogen-Activated Protein Kinases--antagonists & inhibitors
Pancreatic Neoplasms--pathology
Quinazolines--blood
Modulation of drug cytotoxicity by Iressa (ZD1839) in pancreatic cancer cell lines. [electronic resource] - Cancer biology & therapy Oct 2005 - 1089-95 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1538-4047
10.4161/cbt.4.10.1995 doi
Antineoplastic Agents--blood
Apoptosis--drug effects
Carcinoma--pathology
Cell Line, Tumor
Cell Survival--drug effects
Dose-Response Relationship, Drug
Drug Therapy, Combination
Drug-Related Side Effects and Adverse Reactions
Enzyme Inhibitors--blood
ErbB Receptors--antagonists & inhibitors
Gefitinib
Humans
Mitogen-Activated Protein Kinases--antagonists & inhibitors
Pancreatic Neoplasms--pathology
Quinazolines--blood